NEVRO CORP Contracts & Agreements

Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on August 6, 2024)

Promotion Letter, dated May 2, 2024, by and between Christofer Christoforou and the Company (Filed With SEC on August 6, 2024)

Cooperation Agreement, dated February 20, 2024, by and between Nevro Corp., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Engaged Capital Flagship Master Fund, LP and Glenn... (Filed With SEC on February 21, 2024)

Stock Purchase Agreement dated as of November 30, 2023, by and among Interventional Pain Technologies, Inc. d/b/a Vyrsa Technologies, Nevro Corp., the sellers of Interventional... (Filed With SEC on December 1, 2023)

Form of Warrant to Purchase Common Stock of Nevro Corp (Filed With SEC on December 1, 2023)

Credit Agreement and Guaranty, dated as of November 30, 2023, by and among Nevro Corp., as borrower, the subsidiary guarantors from time to time party thereto, the lenders from... (Filed With SEC on December 1, 2023)

Registration Rights Agreement, dated November 30, 2023, by and between Nevro Corp. and the Lenders listed thereto (Filed With SEC on December 1, 2023)

Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on November 1, 2023)

Amended and Restated Employment Agreement, by and between D. Keith Grossman and the Company, effective as of April 24, 2023 (Filed With SEC on August 1, 2023)

Offer Letter, dated as of April 17, 2023, by and between Kevin Thornal and the Company (Filed With SEC on August 1, 2023)

Employment Agreement by and between Kevin Thornal and the Company, effective as of April 24, 2023 (Filed With SEC on August 1, 2023)

Offer Letter, dated as of June 1, 2023, by and between Greg Siller and the Company (Filed With SEC on August 1, 2023)

Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Rod MacLeod and the Company (Filed With SEC on August 1, 2023)

Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Niamh Pellegrini and the Company (Filed With SEC on August 1, 2023)

Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Kashif Rashid and the Company (Filed With SEC on August 1, 2023)

Change in Control Severance Agreement, dated June 20, 2023, between Greg Siller and the Company (Filed With SEC on August 1, 2023)

Separation Agreement, dated June 30, 2023, by and between Niamh Pellegrini and the Company (Filed With SEC on August 1, 2023)

Third Amendment to the Supply Agreement, effective as of November 1, 2021, by and between the Company and Greatbatch Ltd (Filed With SEC on May 4, 2022)

Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 23, 2022)

Second Amended and Restated Company Bonus Plan (Filed With SEC on August 5, 2020)

Offer Letter, dated as of May 15, 2020, by and between Roderick H. MacLeod and the Company (Filed With SEC on August 5, 2020)

Change in Control Severance Agreement, dated as of June 15, 2020, by and between Roderick H. MacLeod and the Company (Filed With SEC on August 5, 2020)

Amendment to Supply Agreement, effective as of July 23, 2019, by and between the Company and Pro-Tech Design and Manufacturing, Inc (Filed With SEC on August 5, 2020)

Form of Performance Stock Award Agreement and Performance Stock Award Grant Notice under the 2014 Equity Incentive Award Plan (Filed With SEC on May 5, 2020)

Assignment, Assumption and Amendment to Supply Agreement, effective as of December 31, 2019, by and between the Company, Greatbatch Ltd. and Centro de Construccion de... (Filed With SEC on May 5, 2020)

Underwriting Agreement, by and between Nevro Corp. and Morgan Stanley & Co. LLC, dated April 1, 2020, related to the Common Stock (Filed With SEC on April 7, 2020)

Underwriting Agreement, by and between Nevro Corp. and Morgan Stanley & Co. LLC, dated April 1, 2020, related to the Notes (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 1, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Base Warrants (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 1, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Base Call Option Transaction (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 1, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Base Warrants (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 1, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Base Call Option Transaction (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 2, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Additional Call Option Transaction (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 2, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Additional Warrants (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 2, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Additional Call Option Transaction (Filed With SEC on April 7, 2020)

Letter Agreement, dated April 2, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Additional Warrants (Filed With SEC on April 7, 2020)

Supplemental Indenture, dated April 6, 2020, by and between Nevro Corp. and Wilmington Trust, National Association, as Trustee (Filed With SEC on April 7, 2020)

Description of Nevro Corp.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2020)

Change in Control Severance Agreement, dated as of September 16, 2019, by and between Niamh Pellegrini and the Company (Filed With SEC on February 25, 2020)

Transition and Separation Agreement, dated as of January 7, 2020, by and between the Company and Doug Alleavitch (Filed With SEC on February 25, 2020)

Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Doug Alleavitch and the Company (Filed With SEC on November 6, 2019)

Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Kashif Rashid and the Company (Filed With SEC on November 6, 2019)

Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Patrick Schmitz and the Company (Filed With SEC on November 6, 2019)

Amended and Restated Change in Control Severance Agreement, effective June 5, 2019, by and between Andrew Galligan and the Company (Filed With SEC on August 8, 2019)

Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on August 8, 2019)

First Amendment to Supply Agreement, effective as of April 30, 2019, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A (Filed With SEC on August 8, 2019)

Employment Agreement by and between D. Keith Grossman and the Company, effective as of March 19, 2019 (Filed With SEC on May 9, 2019)

Separation Agreement, dated March 18, 2019, by and between Rami Elghandour and the Company (Filed With SEC on May 9, 2019)

Settlement Agreement, dated as of March 19, 2019, among Nevro Corp. and Broadfin Capital, LLC and certain of its affiliates (Filed With SEC on March 20, 2019)

Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 21, 2019)

Transition and Separation Agreement by and between the Company and James Alecxih dated July 27, 2018 (Filed With SEC on August 2, 2018)

Amendment No. 2 to Manufacturing and Supply Agreement (Filed With SEC on August 2, 2018)

Amended and Restated Company Bonus Plan (Filed With SEC on May 7, 2018)

Non-Employee Director Compensation Program, as amended (Filed With SEC on May 7, 2018)

Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Patrick Schmitz and the Company (Filed With SEC on February 22, 2018)

Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Christofer Christoforou and the Company (Filed With SEC on February 22, 2018)

Amended and Restated Change in Control Severance Agreement, dated as of December 14, 2017, by and between James Alecxih and the Company (Filed With SEC on February 22, 2018)

Amended and Restated Change in Control Severance Agreement, dated as of December 18, 2017, by and between Kashif Rashid and the Company (Filed With SEC on February 22, 2018)

Third Amendment to Lease, effective as of December 6, 2017, by and between the Company and Westport Office Park, LLC (Filed With SEC on February 22, 2018)

Third Amendment to the Product Supply and Development Agreement, dated as of September 15, 2017, by and between the Company and EaglePicher Medical Power, LLC (Filed With SEC on November 6, 2017)

First Amendment to the Manufacturing and Supply Agreement, dated as of September 30, 2017, by and between the Company and Vention Medical Design and Development, Inc (Filed With SEC on November 6, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on August 7, 2017)

SUPPLY AGREEMENT (Filed With SEC on February 23, 2017)

FIRST AMENDMENT TO LEASE (EXPANSION) (Filed With SEC on February 23, 2017)

NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on November 7, 2016)

GENERAL RELEASE AND SEPARATION AND TRANSITION AGREEMENT (Filed With SEC on August 8, 2016)

NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 8, 2016)

$150,000,000 Nevro Corp. 1.75% Convertible Senior Notes due 2021 Underwriting Agreement (Filed With SEC on June 13, 2016)

NEVRO CORP. INDENTURE Dated as ofJune 13, 2016 Wilmington Trust, National Association Trustee TABLE OF CONTENTS (Filed With SEC on June 13, 2016)

NEVRO CORP. AND WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of June 13, 2016 to Indenture dated as ofJune 13, 2016 1.75% Convertible... (Filed With SEC on June 13, 2016)

Nevro Corp. May 4,2016 (Filed With SEC on May 9, 2016)

NEVRO CORP. EMPLOYMENTAGREEMENT (Filed With SEC on May 9, 2016)

NEVRO CORP. AMENDEDAND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 9, 2016)

SECOND AMENDMENT TO STELLAR MANUFACTURING AGREEMENT (Filed With SEC on February 29, 2016)

SECOND AMENDMENT TO THE PRODUCT SUPPLY AND DEVELOPMENT AGREEMENT (Filed With SEC on February 29, 2016)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on February 29, 2016)

SECOND AMENDMENT TO TERM LOAN AGREEMENT (Filed With SEC on August 6, 2015)

NEVRO CORP. [] Shares ofCommon Stock Underwriting Agreement (Filed With SEC on June 1, 2015)

4040 Campbell Avenue, Suite 210, Menlo Park CA 94025 (Filed With SEC on April 9, 2015)

FIRST AMENDMENT TO THE PRODUCTSUPPLY AND DEVELOPMENT AGREEMENT (Filed With SEC on March 18, 2015)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 18, 2015)

FIRST AMENDMENT TO TERM LOAN AGREEMENT (Filed With SEC on March 18, 2015)

SUPPLY AGREEMENT BETWEEN CENTRO DECONSTRUCCION DE CARDIOESTIMULADORES DEL URUGUAY S.A. AND NEVRO CORP. March 13, 2015 (Filed With SEC on March 18, 2015)

LEASE AGREEMENT By and Between WESTPORT OFFICE PARK, LLC, a California limited liability company (Landlord) and NEVRO CORP., a Delawarecorporation (Tenant) March 5, 2015 TABLE OF... (Filed With SEC on March 18, 2015)

NEVRO CORP. SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 4, 2014)

NEVRO CORP. SECOND AMENDMENT TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 4, 2014)

NEVRO CORP. Shares of Common Stock Underwriting Agreement (Filed With SEC on October 27, 2014)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on October 15, 2014)

STELLAR MANUFACTURING AGREEMENT (Filed With SEC on October 15, 2014)

FIRST AMENDMENT TO STELLAR MANUFACTURING AGREEMENT (Filed With SEC on October 15, 2014)

NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on October 10, 2014)

NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 10, 2014)

NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE (Filed With SEC on October 10, 2014)

NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on October 10, 2014)

NEVRO CORP. 2014 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on October 10, 2014)

NEVRO CORP. INDEMNIFICATION AGREEMENT (Filed With SEC on October 10, 2014)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on October 3, 2014)

STELLAR MANUFACTURING AGREEMENT (Filed With SEC on October 3, 2014)

Category

Industry

Companies

Contracts

NEVRO CORP Contracts & Agreements